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ABSTRACT
The nuclear receptor NR5A1 is equally expressed and required for
development of the gonadal primordia of both sexes, but, after sex
determination, it is upregulated in XY testes and downregulated in
XX ovaries. We have recently demonstrated, in mice, that this
downregulation is mediated by forkhead box L2 (FOXL2) and
hypothesized that adequate suppression of Nr5a1 is essential for
normal ovarian development. Further, analysis of human
patients with disorders/differences of sex development suggests
that overexpression of NR5A1 can result in XX (ovo)testicular
development. Here, we tested the role of Nr5a1 by overexpression
in fetal gonads using a Wt1-BAC (bacterial artificial chromosome)
transgene system. Enforced Nr5a1 expression compromised ovarian
development in 46,XX mice, resulting in late-onset infertility, but did
not induce (ovo)testis differentiation. The phenotype was similar to
that of XX mice lacking Notch signaling. The expression level of
Notch2 was significantly reduced in Nr5a1 transgenic mice, and the
ovarian phenotype was almost completely rescued by in utero
treatment with a NOTCH2 agonist. We conclude that suppression of
Nr5a1 during the fetal period optimizes ovarian development by fine-
tuning Notch signaling.
KEY WORDS: NR5A1, Ad4BP, SF1, Notch signaling, Premature
ovarian insufficiency, Sex determination
INTRODUCTION
Inmammals, gonadal development, including sexual differentiation,
is a unique process in that two completely different organs, testes
and ovaries, arise from a common precursor, the bipotential genital
ridge. Initially, the morphogenesis of the bipotential genital ridge
appears to be similar between male and female embryos, and
involves a suite of genes including empty spiracles homeobox 2
(Emx2), GATA-binding protein 4 (Gata4), two isoforms of Wilms’
tumor 1 (Wt1;Wt1+KTS andWt1–KTS), LIM homeobox 9 (Lhx9),
and nuclear receptor 5a1 (Nr5a1) (She and Yang, 2014).
Sex-specific differentiation of the gonads begins with expression
of the Y-linked gene sex-determining region Y (Sry), the master
switch of male determination in mammals (Koopman et al., 1991),
and its autosomal target gene Sox9 (Sekido and Lovell-Badge,
2008). SOX9 is expressed in pre-Sertoli cells and directly
upregulates a number of male-specific genes in cooperation with
NR5A1, leading to differentiation of Sertoli cells (Wilhelm et al.,
2007), which orchestrate testis development. In the absence of Sry,
female genes such as Wnt4 and Foxl2 are upregulated, leading to
ovarian development (Wilhelm et al., 2007). During ovarian
development, bidirectional communication between germ cells
and somatic granulosa cells leads to follicular development. For
developmental maturation of ovarian follicles, several genes and
molecular pathways are required, such as growth differentiation
factor-9 (Gdf9), bone morphogenetic protein 15 (Bmp15) and
the Notch signaling pathway, to mediate the interaction (Suzuki
et al., 2015).
NR5A1 (also known as Ad4BP or SF1) is a member of the
nuclear receptor superfamily. In mice, Nr5a1 is expressed from
∼9.5 days postcoitum (dpc), in the bipotential genital ridge and the
adrenogenital primordium (Ikeda et al., 2001), and knockout
models show complete gonadal agenesis in both XX and XY,
suggesting that NR5A1 is essential for genital ridge development in
both sexes (Luo et al., 1994; Majdic et al., 2002). In addition to
initiating gonadal development, NR5A1 plays crucial roles in
testicular development. It is transcriptionally upregulated in the
developing mouse testes (Hanley et al., 1999), where it acts as a
cofactor of the male sex-determining factor SRY to induce Sox9
expression (Sekido and Lovell-Badge, 2008). Subsequently, it
cooperates with SOX9 to maintain the expression of Sox9 itself
(Sekido and Lovell-Badge, 2008) and upregulate other Sertoli cell-
specific genes including Amh (De Santa Barbara et al., 1998).
Furthermore, NR5A1 is essential for the differentiation of the
testicular steroidogenic cells, fetal Leydig cells (Buaas et al., 2012).
Consistent with its essential roles in testis differentiation,
heterozygous loss-of-function mutations in NR5A1 cause XY
female sex reversal in humans (Achermann et al., 1999; Correa
et al., 2004; Hasegawa et al., 2004; Mallet et al., 2004).
In contrast to its transcriptional upregulation in fetal testes, Nr5a1
expression in mouse fetal ovaries decreases after 12.5 dpc (Ikeda
et al., 2001). We have recently demonstrated that this downregulation
is mediated by forkhead box L2 (FOXL2), a key ovarian transcription
factor expressed mainly in pregranulosa/granulosa cells (Takasawa
et al., 2014). FOXL2 directly binds to the proximal promoter of
Nr5a1, thereby antagonizing the actions of WT1–KTS that
upregulates the expression of Nr5a1 in collaboration with LHX9.
Recently, 46,XX individuals with testicular or ovo-testicular
disorders/differences of sex development have been reported
carrying mutations in codon 92 of NR5A1, including the R92W
and R92Q mutations (Baetens et al., 2016; Bashamboo et al., 2016;
Igarashi et al., 2017; Miyado et al., 2016; Swartz et al., 2017). TheReceived 10 August 2018; Accepted 4 March 2019
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variant protein was thought to function in the XX gonads by
escaping the suppressive action of NR0B1 (also known as DAX1), a
pro-ovary factor (Igarashi et al., 2017; Miyado et al., 2016; Swain
et al., 1998). The presence of testicular tissue in the probands further
suggested that ectopic activity of NR5A1 may drive testis
differentiation in the absence of the SRY gene.
These observations raise two key questions. First, it is not clear
whether Nr5a1 can function as a male sex-determining factor, i.e.
whether elevated Nr5a1 expression levels in XX gonads (where the
male-determining gene Sry is absent) are sufficient to direct the fate
of gonads towards testicular development. Second, it is not known
whether repression of Nr5a1 is essential for appropriate ovarian
development.
To address these questions, we exploited a bacterial artificial
chromosome (BAC) transgene system (Zhao et al., 2014), whereby
Nr5a1 expression is driven byWt1 regulatory sequences. In the fetal
XX gonads, endogenousWt1 is continuously expressed in supporting
cells including pre-granulosa cells and coelomic epithelium
(Bandiera et al., 2015; Maatouk et al., 2012; Rackley et al., 1993).
Hence, by directing transgenic Nr5a1 expression to Wt1-expressing
XX gonadal supporting cells, we aimed to investigate the
consequence of Nr5a1 overexpression in the relevant cell types in
XX mouse fetal gonads.
Molecular and phenotypic analysis of the two transgenic mouse
lines generated demonstrated first that enforced Nr5a1 expression
alone is insufficient to switch the fate of the 46,XX gonads toward
testicular formation in mice, and, second, that overexpression of
NR5A1 disrupts ovarian follicular development and causes
premature ovarian insufficiency. Because the ovarian phenotype
resembled that of compromising the Notch signaling pathway
(Trombly et al., 2009; Xu and Gridley, 2013; Vanorny et al., 2014),
we conducted further experiments to establish that ectopic NR5A1
acts by dysregulating levels of Notch signaling during gonadal
development.
RESULTS
Overexpression of Nr5a1 fails to cause XX sex reversal
in mice
Using the piggyBac-enabled Wt1-BAC system (Zhao et al., 2014)
(Fig. 1A), we successfully generated two transgenic mouse lines
(Tg-A and Tg-S) expressing an Nr5a1-IRES-Egfp transgene
(Fig. 1B–P). Immunofluorescence (IF) intensity suggested that the
expression levels of NR5A1 and reporter protein EGFP were higher
in the Tg-S line than in Tg-A mice. The expression of exogenous
NR5A1 and EGFP persisted until after birth (Fig. S1A–I).
Quantitative reverse transcriptase PCR (qRT-PCR) also showed
that Nr5a1 mRNA levels were higher in the Tg-S line, although
sample size limited the statistical significance (Fig. 1Q). The
kidneys and adrenal glands, which express endogenousWt1 at high
levels, developed no apparent abnormalities in either Tg-A or Tg-S
mice, suggesting that the gonadal phenotypes of the transgenic mice
were unlikely to be caused by impaired function of those organs.
In both Tg-A and Tg-S lines, XX mice developed female internal
and external genitalia (Fig. S2A–F). Morphologically, the gonads in
adult XX Tg-S mice were streak-like and elongated (Fig. S2F). In
Tg-A mice, fetal ovaries at 15.5 dpc were longer and thinner than
those from wild type (Fig. S3A–D). However, at postnatal day (P) 0,
the shape of the ovaries in Tg-A mice was similar to that in wild-
type mice, indicating that the elongation of the gonads had resolved
by that stage. Since a similar phenotype was reported in Sox4−/−
mice (Zhao et al., 2017), we examined the expression levels of Sox4
in the XX Tg-A gonads at 15.5 dpc and indeed found significantly
reduced expression of Sox4 (Fig. S3E). In Sox4−/− mice, the
expression level of Nr5a1 was not altered (Zhao et al., 2017).
Hence, our data suggest that elevated NR5A1 repressed Sox4,
resulting in abnormal morphology of the fetal ovaries.
In both transgenic lines, histological examination of XX adult
gonads revealed the presence of ovarian follicles but detected no
seminiferous tubule-like structures (Fig. 2; Fig. S2G–J). Consistently,
FOXL2, a marker of ovarian granulosa cells, was expressed in XX
adult gonads in both mouse lines (Fig. 2B,C). In contrast, SOX9, a
marker of testicular Sertoli cells, was not detected (Fig. 2F,G). Based
on these data, we conclude that Nr5a1 overexpression alone is
insufficient to cause XX sex reversal in mice.
Presence of ectopic steroidogenic cells in fetal ovaries
of Nr5a1 trangenic mice
In addition to Sertoli cells, NR5A1 is highly expressed in gonadal
steroidogenic cell lineages in both sexes and is essential for their
differentiation (Buaas et al., 2012; McClelland et al., 2015; Shima
et al., 2013). In males, steroidogenic Leydig cells differentiate
during fetal testis development and produce androgen (Griswold
and Behringer, 2009). In contrast, the ovarian steroidogenic theca
cells do not differentiate until after birth (Suzuki et al., 2015;
Wilhelm et al., 2007). We asked whether overexpression ofNr5a1 is
able to induce the ectopic differentiation of steroidogenic cells in
fetal XX gonads. Immunofluorescence analysis of the XX fetal
gonads of Tg-A and Tg-S mice (Fig. 3A–L) revealed that 3β-
hydroxysteroid dehydrogenase (3β-HSD), the enzyme mediating
the first step of steroidogenesis and a marker of steroidogenic cells
(Peng et al., 2002), was detected in the Tg-S XX gonads (Fig. 3G).
However, the plasma testosterone levels at P0 were not elevated in
XX Tg-S mice compared to wild type (Fig. 3M). This is consistent
with the lack of masculinization in XX Tg-S mice (Fig. S2C,F). On
the other hand, plasma estrogen levels at P0 were significantly lower
in XX Tg-S mice than in wild type (Fig. 3N). The result could be
caused by impaired differentiation of ovarian somatic cells in Tg
mice or to other environmental factors, such as reduced maternal
estrogen.
Enforced expression of Nr5a1 leads to increased follicular
atresia and impaired fertility
After the neonatal period, no obvious dysgenesis or structural
abnormalities were found in Tg-A and Tg-S ovaries. However, at
P14, histological analysis revealed an increased number of multiple-
oocyte follicles (MOFs), suggesting disruption of ovigerous cord
fragmentation (Fig. 4A–D). Further, we found generally reduced
numbers of follicles of all types compared towild type. In particular,
the number of antral follicles (tertiary, type 6–8), characterized by a
fluid-filled cavity, was significantly affected (Fig. 4E). The numbers
of antral follicles appeared to be inversely correlated with Nr5a1
expression levels, with the Tg-S ovaries containing fewer antral
follicles than the Tg-A ovaries (Fig. 4E). To determine whether this
was caused by reduced proliferation or increased apoptosis of
follicular granulosa cells, we analyzed the expression of Ki-67 (also
known as Mki67), a marker of proliferating cells, and cleaved
caspase 3, a marker of apoptotic cells, in transgenic ovaries at P28.
We observed no obvious changes in the follicles containing Ki-67-
positive granulosa cells (red, Fig. 5D–F), but a significant increase
in secondary follicles (type 4 and 5), the precursors of tertiary
follicles, containing cleaved caspase 3-positive granulosa cells
(green) in both Tg-A and Tg-S ovaries (Figs 4F and 5A–C,G–I; the
boxed areas in Fig. 5G–I are shown enlarged in Fig. 5J–L). The
increase in follicular atresia correlated withNr5a1 expression levels,
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with Tg-S ovaries exhibiting higher levels of atresia than Tg-A
ovaries (Figs 4F and 5A–C,G–L). No increase in type 6 antral
follicles containing cleaved caspase 3-positive cells was observed
(Fig. 4F). Together, these results suggest that overexpression of
Nr5a1 caused increased apoptosis of granulosa cells in secondary
follicles in a dose-dependent manner, resulting in reduced numbers
of antral follicles.
We next assessed the fertility of Tg-A and Tg-S female mice. The
fertility of Tg-S female mice was compromised. Of three Tg-S
females analyzed, the litter size was reduced from their first mating
Fig. 1. Generation of transgenic mice with enforced Nr5a1 expression in XX gonads. (A) Schematic representation of the strategy to generate transgenic
mice using the piggyBac-enabled Wt1-BAC system. Nr5a1-IRES-Egfp fragment in the Gateway entry vector was inserted into PBWt1-Dest using LR
recombination. (B–P) Transgenic EGFP expression was detected using IF in the XX fetal gonads at 15.5 dpc in both Tg-A and Tg-S lines. Low-magnification
(B–M), and high-magnification (N–P) images revealed that EGFP (green) and NR5A1 (red) were expressed in the cytoplasm and nucleus, respectively, of the
same cells in XX transgenic mice (arrows) (O,P). By using cryosections and paraffin-embedded samples, at least three sections from each of at least three
gonads were examined for each genotype. The images were obtained from the cryosection samples. Scale bars: 25 μm (B–M) and 10 μm (N–P). Dashed lines
indicate the edge of the gonad. (Q) qRT-PCR analysis showing that Nr5a1 was expressed at different levels in the XX fetal gonads of the Tg-A and Tg-S lines at
P0. In the XX fetal gonads of the Tg-S line,Nr5a1was expressed at levels similar to those in wild-type testes. In the Tg-A line,Nr5a1was expressed in the XX fetal
gonads at levels between those in wild-type testes and ovaries. Expression levels were normalized to Rps29. Mean±s.d., n=3. *P<0.05 (Welch’s t-test).
A, Tg-A; S, Tg-S; WT, wild type.
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(Fig. 4G). The reproductive performance of Tg-A females was also
reduced. Although Tg-A mice produced four consecutive litters to
begin the study, they failed to produce additional litters thereafter
(Fig. 4H), suggesting that these females had premature reproductive
senescence, analogous to premature ovarian insufficiency in human.
Nr5a1 overexpression represses Notch signaling levels in
fetal ovaries
Interactions between germ cells and somatic pregranulosa cells are
crucial for the formation of ovarian follicles, and Notch signaling
plays a major role in mediating this interaction (Terauchi et al.,
Fig. 2. Transgenic overexpression of Nr5a1 in XX fetal gonads
did not induce male development. (A–L) IF analysis of markers of
granulosa (FOXL2, red) or Sertoli cells (SOX9, green) of the gonads
in adult mice (6–8 months old). In the XX gonads of the Tg-A and
Tg-S lines, only FOXL2-positive granulosa cells were present (B,C),
and no SOX9-positive cells were detected (F,G; some nonspecific
staining of the oocytes was seen using the anti-SOX9 antibody). In
XX gonads, white solid lines indicate the gonadal edges; white and
yellow dashed lines indicate the outlines of the ovarian follicles and
the oocytes, respectively. Granulosa cells were identified by FOXL2
expression between white and yellow dashed lines. In XY gonads,
whited dashed lines indicate testicular tubules. Scale bars: 25 µm.
Fig. 3. Formation of ectopic steroidogenic cells in the XX
transgenic fetal gonads. (A–L) IF analysis of 3β-HSD, a marker of
steroidogenic cells, at 15.5 dpc. In the Tg-S fetal ovaries, 3β-HSD-
positive cells were sparsely observed, some of which showed
colocalization with NR5A1 (G,K, arrows). Scale bars: 25 µm. (M,N)
Plasma testosterone (M) or estradiol (N) levels at P0. No significant
increase in the levels of testosterone was observed in XX Tg-A or
Tg-S mice compared with wild-type female mice. Mean±s.e.m., n=3.
*P<0.05 (Welch’s t-test).
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2016; Vanorny et al., 2014; Xu and Gridley, 2013). In the
developing ovaries, oocytes and other neighboring cells secrete the
Notch ligands, including JAG1 and possibly JAG2, which bind to
Notch receptors (mainly NOTCH2) present on the surface of pre-
granulosa cells, thereby activating Notch signaling (Guruharsha
et al., 2012). As a result, pre-granulosa cells proliferate and
encapsulate individual germ cells to form primordial follicles, i.e.
the resolution of germ cell syncytia (Terauchi et al., 2016). Genetic
ablation of either Jag1 or Notch2, two important Notch pathway
components, gives rise to MOFs and causes premature reproductive
senescence (Vanorny et al., 2014). Because of the similarity in the
phenotypes between our Nr5a1 transgenic mice and Jag1- or
Notch2-deficient mice, we hypothesized that enforced expression of
Nr5a1 may compromise ovarian development by repressing the
Notch signaling pathway.
We therefore analyzed mRNA expression levels of a number of
genes involved in Notch signaling in 15.5-dpc fetal ovaries using
qRT-PCR (Fig. 6A–H). Supporting our hypothesis, we found
significant downregulation of several Notch pathway genes,
including Notch2, Notch3 and Dll4, in Tg-A ovaries compared
with wild-type ovaries (Fig. 6B,C,H).
A NOTCH2 agonist rescues the ovarian phenotype
in Tg-A mice
To further clarify the contribution of Notch signaling to the ovarian
phenotype in Nr5a1 transgenic mice, we attempted a rescue
experiment with a NOTCH2 agonist HMN2-29, a hamster
monoclonal antibody (Tanaka et al., 2014). We injected three doses
of HMN2-29 or control hamster IgG intraperitoneally into pregnant
mice carrying wild-type or Tg-A fetuses at 13.5, 16.5 and 18.5 dpc
(Fig. S4A), and analyzed the ovaries postnatally (P14 and P28). No
obvious adverse effects of in utero administration of the NOTCH2
agonist were observed, as the treated mice appeared grossly normal,
with body weight comparable to wild type at P28 (Fig. S4B).
Confirming our hypothesis, we found a reduced number of MOFs
in Tg-Amice at P14 uponHMN2-29 treatment (Fig. 7A).Moreover,
treatment with theNOTCH2 agonist completely restored the number
of antral follicles in XX Tg-A ovaries at P28 towild-type XX levels,
whereas control treatment with hamster IgG did not ameliorate the
reduced follicle number (Fig. 7B). Immunofluorescence analysis for
markers of cell proliferation (Ki-67, red) or apoptosis (cleaved
caspase 3, green) in the XX gonads of the wild-type and Tg-A mice
revealed that the complete rescue of antral follicle numbers appeared
to be a result of reduced atresia of secondary follicles in the treated
ovaries (Fig. 7C–O; the boxed areas in Fig. 7L–O are shown
enlarged in Fig. 7P–S). These results suggest that Nr5a1 fine-tunes
Notch signaling levels in fetal ovaries to ensure proper
folliculogenesis and normal fertility, and that repression of Nr5a1
during fetal ovarian development is essential to allow the Notch
signaling levels to elevate appropriately.
We further explored molecular mechanisms by which the Notch
signaling pathway regulates fetal ovarian development. To this end,
we analyzed the expression levels of two master regulators of ovarian
development,Wnt4 and Foxl2, in Tg-A ovaries at P0. We found that
Wnt4, but not Foxl2, was significantly downregulated in Tg-A mice
compared to wild type (Fig. 7T,U). Importantly, Wnt4 expression in
the Tg-A ovaries was fully restored by the administration of HMN2-
29 (Fig. 7U), suggesting that downregulated expression was a result
of de-regulated Notch signaling pathway rather than a direct effect of
NR5A1 overexpression. Despite the limited statistical significance,
possibly due to the limited size of samples, the Foxl2 expression
pattern was similar to that of Wnt4, suggesting the possibility that
Fig. 4. Impaired ovarian development in Nr5a1 transgenic
mice. (A–C) Histological analysis of ovaries in wild-type, Tg-A
and Tg-S females. MOFs were observed in Tg-A and Tg-S
ovaries (arrowheads). Scale bars: 250 µm. (D) Numbers of
MOFs were counted from serial ovarian sections. Mean
±s.e.m., n=3. *P<0.05 (Welch’s test). (E) The numbers of
antral follicles (type 6–8) significantly decreased in transgenic
mice. The numbers of follicles of each type [1–2 (primordial),
3 (primary), 4–5 (secondary), 6–8 (antral), death and intact]
were counted from serial ovarian sections. Mean±s.d., n=3.
*P<0.05 (Welch’s t-test). (F) Quantification of secondary
follicles containing cleaved caspase 3-positive cells
(Fig. 5A–C). The percentage of cleaved caspase 3-positive
follicles was plotted. Mean±s.e.m., n=3. *P<0.05, **P<0.01
(Welch’s t-test). (G) Average litter size of the first mating of
wild-type, Tg-A and Tg-S female mice (n=3). Mean±s.e.m.
*P<0.05 (Welch’s t-test). (H) Total number of progeny from
wild-type, Tg-S and Tg-A female mice (n=3).
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Foxl2 could be also partially regulated by Notch signaling. We note
that this regulatory relationship is likely limited to the late-stage fetal
ovaries, as expression of the Notch pathway genes starts in fetal
ovaries from ∼15.5 dpc (Vanorny et al., 2014).
DISCUSSION
Nr5a1 plays known essential roles in the development of genital
ridges in both sexes and fetal testes in male mice. We show in the
present study that the downregulation of Nr5a1 is important for
establishing normal Notch signaling in themouse fetal ovary, and that
overexpression ofNr5a1 compromises ovarian development in mice.
Overexpression of Nr5a1 alone is insufficient to drive testis
determination and differentiation in mice
TheWt1-BAC system we used drives robust expression of transgene
cargo to fetal testes and ovaries from an early stage of their
development (Zhao et al., 2014). Using this system, enforced
expression of Dmrt1 in XX mouse fetal gonads has been shown to
drive testicular differentiation (Zhao et al., 2015), indicating the
suitability of this system to test whether a given molecule has the
ability to cause XX sex reversal. Clearly, forced expression of
Nr5a1mRNA and protein was unable to stimulate XX sex reversal.
Although we cannot exclude the possibility that some transient sex
reversal might have occurred earlier than the time points studied, we
consider this unlikely because there is no example to date of
transient sex reversal that resolves to ovaries. Accordingly, we
concluded that overexpression of Nr5a1 alone is insufficient to
drive testis determination and differentiation in mice.
Our results are consistent with the published observation that XX
mice carrying heterozygous or homozygous R92W mutation in
Nr5a1 showed no signs of masculinization (Miyado et al., 2016).
The R92W variant of NR5A1 is thought to escape the suppressive
action of NR0B1, a pro-ovary factor (Igarashi et al., 2017; Miyado
et al., 2016; Swain et al., 1998). Our data, together with the R92W
observation in mice, are at odds with the presence of testicular or
ovo-testicular material in XX humans carrying the R92W variant
(Baetens et al., 2016; Bashamboo et al., 2016; Igarashi et al., 2017;
Miyado et al., 2016; Swartz et al., 2017). One possible explanation
is that NR5A1 may be required at different threshold levels with
respect to sex determination in humans and mice. For example, it is
Fig. 6. Expression of the Notch signaling pathway genes in XX Tg-Amice. (A–H) qRT-PCR analysis was performed on total RNA extracted from fetal ovaries
of wild-type, Tg-A, and Tg-S mice at 15.5 dpc. Expression levels were normalized to Rps29. Mean±s.e.m., n=3. *P<0.05, **P<0.01 (Welch’s t-test).
Fig. 5. IF analysis in ovaries of Nr5a1 transgenic mice. (A–L) IF analysis of
markers of cell proliferation (Ki-67, red) or apoptosis (cleaved caspase 3,
green) in the XX gonads of wild-type, Tg-A and Tg-S mice. The boxed areas in
G–I are shown enlarged in J–L. Orange and white arrows indicate secondary
follicles (type 4–5) with or without cleaved caspase 3-positive cells,
respectively. Scale bars: 30 µm (J–L) and 200 µm (A–I).
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known that duplication of NR0B1, an orphan nuclear receptor gene,
causes XY female sex reversal in humans (Zanaria et al., 1994),
whereas transgenic overexpression of Nr0b1 in mice does not
normally cause female sex reversal in C57BL mice (Swain et al.,
1998). Not only does this demonstrate the principle of different gene
dosage requirements in mouse and human sex determination, but
also, since a major function of NR0B1 is to antagonize NR5A1
(Ikeda et al., 2001; Ludbrook et al., 2012; Zanaria et al., 1994), it
could provide a mechanistic link between different dosage
requirements of NR0B1 and NR5A1 between mouse and human.
NR5A1 promotes differentiation of 3β-HSD-positive cells
Our results reveal a novel function of NR5A1 in the negative
regulation of the Notch signaling pathway during fetal ovarian
development. In addition to its critical functions in ovarian
development, Notch signaling also plays a pivotal role in fetal
testis development, particularly in the differentiation of fetal Leydig
cells. Notch signaling restricts fetal Leydig cell differentiation by
promoting and maintaining progenitor cell fate (Tang et al., 2008).
Interestingly, NR5A1 has been suggested to promote fetal Leydig
cell differentiation by suppressing Notch signaling in this context
(Inoue et al., 2016).
Consistent with these reports, we found that overexpression of
NR5A1 in the fetal ovaries of Tg-S mice led to the differentiation of
3β-HSD-positive cells, presumably ectopic fetal Leydig cells, at
15.5 dpc. However, the presence of these cells did not lead to an
increase in plasma testosterone levels at birth. There may be too few
3β-HSD-positive cells in the transgenic ovaries: this is borne out by
Fig. 7. Administration of a NOTCH2 agonist rescued the ovarian phenotype in Tg-A mice. (A,B) The NOTCH2 agonist HMN2-29 or control hamster IgG
was in utero administered to wild-type or Tg-A mice, and the ovarian phenotypewas analyzed at P14 (A) and P28 (B). HMN2-29 administration almost completely
rescued the formation of MOFs in the Tg-A ovaries at P14 (A), and restored the antral follicles to the wild-type level at P28 (B). Mean±s.e.m., n=3. *P<0.05
(Welch’s t-test). (C–S) IF analysis, at P28, of markers of cell proliferation (Ki-67, red) or apoptosis (cleaved caspase 3, green) in XX gonads of wild-type and
Tg-A mice treated with hamster IgG or HMN2-29. White and orange arrows indicate secondary follicles (type 4–5) with or without cleaved caspase 3-positive
granulosa cells, respectively. Scale bars: 25 µm (P–S) and 200 µm (D–O). Quantitation of caspase 3-positive follicles in D–G is shown in C. The boxed
areas in L–O are shown enlarged in P–S. Mean±s.e.m., n=3. **P<0.01 (Welch’s t-test); ns, not significant. (T,U) qRT-PCR analysis for Foxl2 (T)
and Wnt4 (U) in P0 gonads of wild-type or Tg-A mice treated with hamster IgG or HMN2-29, respectively. Expression levels were normalized to Rps29.
Mean±s.e.m., n=3. *P<0.05 (Welch’s t-test). ns, not significant.
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the fact we did not find significant elevation of Hsd3b gene
expression in the Tg-S fetal ovaries by qRT-PCR analysis (data not
shown). A recent report revealed that fetal Leydig cells do not have
the capacity to produce testosterone because they do not express
17β-HSDs, essential for the last step of testosterone synthesis
(O’Shaughnessy et al., 2000; Shima et al., 2013). Hence, although
some ectopic 3β-HSD-positive presumptive fetal Leydig cell
differentiation occurred in the Tg-S mice, the absence of Sertoli
cells expressing 17β-HSD (which convert androstenedione to
testosterone) means that no testosterone can be produced.
Fetal gonadal development requires optimal levels of Nr5a1
and Notch signaling
Although exogenous Nr5a1 continued to be expressed after birth
(Fig. S1D–L), it is likely that ectopic expression of Nr5a1 during
fetal life is responsible for the observed ovarian phenotype in the
transgenic mice. First, the phenotype could be rescued by injecting
the NOTCH2 agonist during the fetal period. It is most likely that
this rescue was caused by specific targeted effects of the antibody,
based on previous studies. It has been estimated that the half-life of
administered monoclonal antibodies in mice is 6–8 days (Vieira and
Rajewsky, 1988). In human, the half-life is 2–3 weeks, explaining
why, in current clinical practice, monoclonal antibodies are widely
used for the therapy of intractable diseases, such as autoimmune and
malignant diseases. In the case of HMN29-2, the monoclonal
antibody used in the present study, the specificity and
pharmacological effects in vitro and in vivo were established
previously using a podocyte culturing system (Tanaka et al., 2014).
In the present study, we administered hamster IgG as a negative
control, and found that it did not ameliorate the phenotype of the Tg
mice. Taken together, the evidence suggests that the effects
observed result from sustained and specific recognition of the
target Notch in the ovary, and that perturbations of Notch signaling
underpin the phenotype of the Tg mice.
Second, in ovarian development, the regulation of Notch
signaling by NR5A1 may be context dependent and limited to the
fetal stage, since the mRNA levels of Notch2/3 and Nr5a1 are
known to simultaneously increase after birth (Hinshelwood et al.,
2005; Vanorny et al., 2014). Third, one of the major phenotypes of
the Tg-A and Tg-S mice is MOFs, which are caused by abnormal
nest breakdown in the perinatal period.
Regarding the mechanisms underpinning subfertility in the Tg-A
mice, a previous study of a Jag1 knockout mouse model with
reduced Notch signaling revealed a similar subfertility phenotype,
although the total number of follicles remained unchanged from
wild type (Vanorny et al., 2014). In our Tg-A mice, the number of
follicles was similarly unaffected. The phenotypes of Tg-S mice,
including apoptosis of follicular cells, would also be caused by
the same pathophysiology as Tg-A mice, because the phenotypes of
Tg-S mice are similar but more severe. These are in line with the
higher expression level of the transgene in Tg-S than that in Tg-A.
Further study is required to shed light on the apparent functions of
Notch signaling in ovarian development.
Based on our data presented here, and published data, we propose
a model of NR5A1 function in fetal gonadal development (Fig. 8).
The sexually dimorphic expression pattern of Nr5a1 in the
developing fetal gonads allows Notch signaling activity to be
tuned to optimal levels to suit distinct developmental programs. In
fetal ovaries, downregulated Nr5a1 de-represses Notch signaling,
thereby allowing appropriate follicular development. On the other
hand, elevated levels of NR5A1 in fetal testes represses Notch
signaling, allowing fetal Leydig cells to differentiate.
Our model suggests that an optimal level ofNr5a1 in fetal ovaries
is required for proper development of follicles, and that either
insufficient or excessive Nr5a1 expression in fetal ovaries leads to
impaired ovarian development. Consistent with this model, Cited2-
null mice with severely reduced Nr5a1 expression in fetal ovaries
showed impaired expression of several ovarian marker genes
(Combes et al., 2010), suggesting that low levels of Nr5a1
expression are required for ovarian development. Similarly,
women carrying loss-of-function mutation in NR5A1 often
develop premature ovarian insufficiency (Lourenço et al., 2009).
On the other hand, mild upregulation of Nr5a1 expression in Tg-A
mice was sufficient to impair follicular development and female
fertility, even though the increase in expression was very mild
compared to wild-type ovaries.
In summary, our study provides novel insight into the molecular
pathways regulating fetal ovarian development, about which little is
currently understood. We show that insufficiently repressed Nr5a1
during fetal ovarian development leads to compromised follicular
development and fertility issues due to dysregulated Notch
signaling. Alterations in Nr5a1 dosage, either reduced or
excessive, result in pathological effects in ovarian development
and female fertility, indicating that the precise control of Nr5a1 at
the transcriptional level is essential for optimal ovarian
development. Further studies are required to reveal molecular
details of the NR5A1–Notch–WNT4 axis in fetal ovarian
development. We envisage that the improved understanding of
how this pathway regulates ovarian development and female
fertility would aid the development of artificial somatic ovarian
cells, which in turn may provide a valuable treatment option in
reproductive medicine.
MATERIALS AND METHODS
Generating transgenic mice
The mouse transgenesis procedure was based on a protocol described
previously (Zhao et al., 2014). Briefly, a sequence containing the mouse
Nr5a1 coding region followed by an internal ribosomal entry site and the
sequence encoding enhanced green fluorescent protein (Nr5a1-IRES-Egfp)
was cloned into the PBWt1-Dest vector via Gateway LR recombination
(Fig. 1A). Transgenic founder mice were produced by pronuclear injection
of the PBWt1-Nr5a1-IRES-Egfp vector DNA and hyperactive piggyBac
Fig. 8. A model for NR5A1 function in fetal gonadal development in mice.
NR5A1 fine-tunes Notch signaling levels to achieve optimal developmental
outcomes in both fetal ovaries.
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transposase mRNA as described. The XY male founders mated with BDF1
females, and transmitted the transgene through the germ line. For
subsequent analyses, we chose two lines, Tg-A and Tg-S. Both lines were
maintained by mating F0 or F1 XY transgenic male mice with BDF1 wild-
type females. Genotyping and sexing was performed by PCR (primer
sequences are listed in Table S1) using genomic DNA prepared from tail or
ear biopsies. All animal procedures were approved by the Institutional
Animal Care and Use Committee of Tokyo Medical and Dental University.
Fertility analysis of transgenic female mice
The fertility of Tg-A and Tg-S female mice, compared with that of wild-type
female mice, was assessed after they turned 6 weeks old by continuous
mating with ∼30-week-old BDF1 male mice. Three female mice from each
line were analyzed. The average number of offspring in the first litter and the
aggregated number of offspring from all litters were calculated for each
genotype.
Real-time qRT-PCR analysis
RNA was extracted from 15.5 dpc or P0 mice gonads using a Qiagen
RNeasy Mini kit according to the manufacturer’s instructions. Typically,
0.2 μg total RNA was reverse transcribed using random hexamers
(Promega) and SuperScript III reverse transcriptase (Invitrogen). qRT-
PCRwas conducted using a LightCycler System (Roche Diagnostics, Basel,
Switzerland) with the LightCycler DNA Master SYBR Green Kit (Roche)
for 45 cycles. Gene expression levels were analyzed using the comparative
cycle time (Ct) method. Primers used in these experiments are listed in
Table S1. Ribosomal protein S29 (Rps29) served as the housekeeping gene
for normalization, as it shows minimum variability during fetal gonadal
development (Svingen et al., 2009).
Histological analyses
Cryosections
Gonadal samples were fixed overnight in 4% paraformaldehyde (PFA) at
4°C. After washing three times with PBS, samples were incubated overnight
in 20% sucrose/PBS at 4°C. Samples were then incubated in 30% sucrose/
OCT at 40°C for 30 min and embedded.
Paraffin sections
Gonadal samples were fixed overnight in 4% PFA at 4°C and embedded in
paraffin. The blocks were sectioned at 6-µm thickness and were later
deparaffinized as previously described (Suzuki et al., 2010).
Hematoxylin and Eosin staining
After staining with 2× Hematoxylin for 4 min, the sections were washed for
12 min under running water and then stained with 1.0% Eosin for 2 min.
IF
Cryosections and paraffin sections were used for IF. For cryosections, 8-µm
samples were washed twice with PBS and activated with citric acid solution.
The sections were blocked with 5% bovine serum albumin-PBS at room
temperature for 1 h, followed by overnight incubation with the primary
antibody at 4°C. Next, the sections werewashed twicewith PBSwith Tween
20 (PBS-T), incubated with the secondary antibody at room temperature for
1.5 h, and again washed twice with PBS-T. Finally, the sections were
incubated with 4′,6-diamidino-2-phenylindole (DAPI; Dojindo, 1:1000) for
5 min, washed once with PBS-T and mounted in Fluoromount™.
Information on antibodies used in this study is provided in Table S2.
Counting numbers of follicles, apoptotic follicles or MOFs
Counting was performed as previously described (Xu and Gridley, 2013).
Briefly, serial sections (6-μm thick) from a whole ovary were placed on five
slides, each slide containing sequential slices at every 30-μm interval
(6 μm×5 slides). The sections analyzed cover the entire ovary, and we thus
counted the total number of follicles across the ovary. MOFs were defined as
follicles containing more than a single oocyte (Myers et al., 2004; Pedersen
and Peters, 1968). Anti-MVH (also known as DDX4) antibody (ab13840,
Abcam) and 3,3′-diaminobenzidine (DAB; 25985-50, Nacalai Tesque)
staining was used to count the number of follicles and MOFs. The types of
follicles were classified according to previous reports (Myers et al., 2004;
Pedersen and Peters, 1968), i.e. the 1–2, 3, 4–5 and 6–8 follicular types
correspond to ‘primordial’, ‘primary’, ‘secondary’ and ‘antral/tertiary’
follicles, respectively. We used anti-cleaved caspase 3 (9579, Cell Signaling
Technology) to identify apoptotic granulosa cells and calculated the
percentage of caspase 3-positive follicles. For quantification, three samples
from each mouse were analyzed.
Hormone measurements
Free testosterone and estradiol levels of P0 mice were measured using
commercially available ELISA kits (DB52181, IBL International; 582251,
Cayman Chemical). Three sets of plasma samples obtained from each of
five mice were analyzed according to the manufacturer’s protocol.
Preparation and administration of the NOTCH agonist HMN2-29
BDF1 eggs were fertilized in vitro with Tg-A sperm and transplanted into
the oviducts of ICR mice. The NOTCH2 agonist HMN2-29, a hamster
monoclonal antibody, was prepared as described previously (Tanaka et al.,
2014). Three doses of 0.5 mg HMN2-29 or control hamster IgG (145-
19561, Wako) were intraperitoneally injected into pregnant ICR mice at
13.5, 16.5 and 18.5 dpc.
Statistical analysis
We used the unpaired t-test (Welch’s test) to demonstrate that a given sample
differed statistically from wild-type control (Figs 1 and 3–6) in a direct two-
point comparison. We consulted our Institute statistics experts to confirm
that this is appropriate.
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